Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

526 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs).
de Oliveira AT, Pinheiro C, Longatto-Filho A, Brito MJ, Martinho O, Matos D, Carvalho AL, Vazquez VL, Silva TB, Scapulatempo C, Saad SS, Reis RM, Baltazar F. de Oliveira AT, et al. Among authors: reis rm. J Bioenerg Biomembr. 2012 Feb;44(1):171-8. doi: 10.1007/s10863-012-9408-5. Epub 2012 Jan 27. J Bioenerg Biomembr. 2012. PMID: 22281667
Frequency of TERT promoter mutations in human cancers.
Vinagre J, Almeida A, Pópulo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, da Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simões M, Lima J, Máximo V, Soares P. Vinagre J, et al. Among authors: reis rm. Nat Commun. 2013;4:2185. doi: 10.1038/ncomms3185. Nat Commun. 2013. PMID: 23887589 Free article.
Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.
Silva-Oliveira RJ, Silva VA, Martinho O, Cruvinel-Carloni A, Melendez ME, Rosa MN, de Paula FE, de Souza Viana L, Carvalho AL, Reis RM. Silva-Oliveira RJ, et al. Among authors: reis rm. Cell Oncol (Dordr). 2016 Jun;39(3):253-63. doi: 10.1007/s13402-016-0270-z. Epub 2016 Feb 26. Cell Oncol (Dordr). 2016. PMID: 26920031
Anti-EGFR Therapy: Strategies in Head and Neck Squamous Cell Carcinoma.
Oliveira-Silva RJ, Carolina de Carvalho A, de Souza Viana L, Carvalho AL, Reis RM. Oliveira-Silva RJ, et al. Among authors: reis rm. Recent Pat Anticancer Drug Discov. 2016;11(2):170-83. doi: 10.2174/1574892811666160309121238. Recent Pat Anticancer Drug Discov. 2016. PMID: 26955963
Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation.
Sandri S, Faião-Flores F, Tiago M, Pennacchi PC, Massaro RR, Alves-Fernandes DK, Berardinelli GN, Evangelista AF, de Lima Vazquez V, Reis RM, Maria-Engler SS. Sandri S, et al. Among authors: reis rm. Pharmacol Res. 2016 Sep;111:523-533. doi: 10.1016/j.phrs.2016.07.017. Epub 2016 Jul 18. Pharmacol Res. 2016. PMID: 27436149 Free article.
526 results